Profiles of hemophiliac patients and healthy individuals studied
Group (HCV/HIV RNA) . | No. . | Age (y)* . | Hemophilia A/B . | Anti-HCV (%) . |
---|---|---|---|---|
Hemophiliac patients | ||||
A1 (−/−) | 31 | 17.3 ± 2.4† | 27/4 | 11 (35.5) |
B (+/−) | 60 | 32.9 ± 1.4 | 50/10 | 60 (100.0) |
C (−/+) | 10 | 29.2 ± 2.4 | 7/3 | 10 (100.0) |
D (+/+) | 29 | 29.6 ± 1.8 | 19/10 | 29 (100.0) |
Total | 130 | 28.2 ± 1.1 | 103/27 | 110 (84.6) |
Healthy individuals | ||||
A2 (−/−) | 30 | 29.3 ± 0.8 | 0/0 | 0 (0.0) |
Group (HCV/HIV RNA) . | No. . | Age (y)* . | Hemophilia A/B . | Anti-HCV (%) . |
---|---|---|---|---|
Hemophiliac patients | ||||
A1 (−/−) | 31 | 17.3 ± 2.4† | 27/4 | 11 (35.5) |
B (+/−) | 60 | 32.9 ± 1.4 | 50/10 | 60 (100.0) |
C (−/+) | 10 | 29.2 ± 2.4 | 7/3 | 10 (100.0) |
D (+/+) | 29 | 29.6 ± 1.8 | 19/10 | 29 (100.0) |
Total | 130 | 28.2 ± 1.1 | 103/27 | 110 (84.6) |
Healthy individuals | ||||
A2 (−/−) | 30 | 29.3 ± 0.8 | 0/0 | 0 (0.0) |